"Receptor Radionuclide Therapy With 177Lu-DOTATOC

Clinical trial NCT06045260 · RECRUITING

Trial details

NCT number: NCT06045260
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumors Paraganglioma Pheochromocytoma

Start date: 2023-09-13
Primary completion: 2025-02-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.